Babylon (NYSE: BBLN) (the “Company”) today announced it will host a conference call to review its first quarter financial results on Wednesday, May 10, 2023, at 8:00 AM Eastern Time. A press release...
Babylon (NYSE: BBLN), a global digital healthcare company, announced today personalized, digital-first programs for high-risk members living with chronic conditions. The care pathways were developed hand-in-hand...
Babylon Holdings Limited (NYSE: BBLN) (“Babylon” or the “Company”) today announced its financial and operating results for the fourth quarter and fiscal year ended December 31, 2022.
Babylon (NYSE: BBLN) (the “Company”) today announced it will host a conference call to review its fourth quarter and full year 2022 financial results on Thursday, March 9, 2023, at 8:00 AM Eastern...
Babylon Holdings Limited (NYSE: BBLN) (“Babylon” or the “Company”) today confirmed that its revenue for the year ended December 31, 2022 is expected to exceed $1.05 billion on both a U.S. GAAP...
Babylon (NYSE: BBLN) (“Babylon'') today announced additional details concerning the previously announced 1-for-25 reverse share split (the “Reverse Share Split") of its Class A ordinary shares, par...
Babyl, a subsidiary of Babylon (NYSE: BBLN), and Novo Nordisk announced today that they have entered an innovative partnership to contribute to the expansion of diabetes awareness and care in Rwanda. Drawing...
Babylon (NYSE: BBLN) announced today that it will offer Fitbit devices and services to a subset of members that doesn’t currently have access to wearables and that fit health program criteria to promote...
Babylon Holdings Limited (NYSE: BBLN) (“Babylon”) today announced its financial and operating results for the third quarter ended September 30, 2022.
Babylon (NYSE: BBLN) (“Babylon'') today announced that it is proceeding with a 1-for-25 reverse share split (the “Reverse Share Split") of its Class A ordinary shares, par value $0.0000422573245084686...